After adjusting for age, gender, histological subtype and tumor grade, the dosage and expression of NFKBIA remained significant prognostic factors for both 5-year survival (dosage: HR = 2.15, P = 0.016; expression: HR = 0.54, P = 0.002; Tables 4 and 5) and 5-year RFS (dosage: HR = 3.11 P = 0.009; expression: HR = 0.61, P = 0.005; Tables 4 and 5). This evidence concerns the gene NFKBIA and neoplasm.